Cargando…
Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: New conduction disturbances are common complications following transcatheter aortic valve implantation (TAVI). The last ESC guidelines recommended electrophysiological study (EPS) or long-term monitoring for patients with new LBBB...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206764/ http://dx.doi.org/10.1093/europace/euad122.389 |
_version_ | 1785046300176154624 |
---|---|
author | Perel, N Tovia-Brodie, O Schnur, A Glikson, M Michowitz, Y |
author_facet | Perel, N Tovia-Brodie, O Schnur, A Glikson, M Michowitz, Y |
author_sort | Perel, N |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: New conduction disturbances are common complications following transcatheter aortic valve implantation (TAVI). The last ESC guidelines recommended electrophysiological study (EPS) or long-term monitoring for patients with new LBBB above 150 ms or one that is associated with PR prolongation (IIa indication). For patients with preexisting conduction abnormality and further PR or QRS prolongation EPS or long-term monitoring are also recommended but with a IIb recommendation. The data regarding the prognosis and management of patients with isolated PR prolongation is limited. PURPOSE: Evaluate the need for permanant pacmaker implantation, occurance of syncope and mortality during the 1st year following Transcatheter aortic valve implantation METHODS: All patients undergoing TAVI at Shaare Zedek Medical Center were retrospectively reviewed. All patients underwent at least 1 ECG prior and daily post the procedure. Patients with isolated PR prolongation > 20 ms compared to baseline ECG were included. While patients with preexisting permanent pacemaker (PPM), complete AV block or any peri or post procedural QRS widening > 20 ms were excluded. Patient were followed for 1 year for the occurrence of syncope, PPM or death. RESULTS: Excluding patients with preprocedural PPM, 1028 patients were reviewed. Compared to baseline ECG, 124 (12%) patients had isolated PR prolongation, of whom 88 (71%) and 36 (29%) had baseline narrow and wide QRS respectively. During follow-up none of these 88 patients with baseline narrow QRS required in hospital PPM, while only 2 patients with baseline wide QRS required in hospital PPM. During 1 year follow-up, 6 patients (4.8%) died and no one had syncopal episode or need for PPM. CONCLUSION: Post TAVI, isolated new PR prolongation is not associated with an adverse outcome including syncope or progression to complete heart block and need for PPM at 1 year post the procedure. These finding may be considered when evaluating these patients post the procedure. |
format | Online Article Text |
id | pubmed-10206764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102067642023-05-25 Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation Perel, N Tovia-Brodie, O Schnur, A Glikson, M Michowitz, Y Europace 14.1 - Antibradycardia Pacing FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: New conduction disturbances are common complications following transcatheter aortic valve implantation (TAVI). The last ESC guidelines recommended electrophysiological study (EPS) or long-term monitoring for patients with new LBBB above 150 ms or one that is associated with PR prolongation (IIa indication). For patients with preexisting conduction abnormality and further PR or QRS prolongation EPS or long-term monitoring are also recommended but with a IIb recommendation. The data regarding the prognosis and management of patients with isolated PR prolongation is limited. PURPOSE: Evaluate the need for permanant pacmaker implantation, occurance of syncope and mortality during the 1st year following Transcatheter aortic valve implantation METHODS: All patients undergoing TAVI at Shaare Zedek Medical Center were retrospectively reviewed. All patients underwent at least 1 ECG prior and daily post the procedure. Patients with isolated PR prolongation > 20 ms compared to baseline ECG were included. While patients with preexisting permanent pacemaker (PPM), complete AV block or any peri or post procedural QRS widening > 20 ms were excluded. Patient were followed for 1 year for the occurrence of syncope, PPM or death. RESULTS: Excluding patients with preprocedural PPM, 1028 patients were reviewed. Compared to baseline ECG, 124 (12%) patients had isolated PR prolongation, of whom 88 (71%) and 36 (29%) had baseline narrow and wide QRS respectively. During follow-up none of these 88 patients with baseline narrow QRS required in hospital PPM, while only 2 patients with baseline wide QRS required in hospital PPM. During 1 year follow-up, 6 patients (4.8%) died and no one had syncopal episode or need for PPM. CONCLUSION: Post TAVI, isolated new PR prolongation is not associated with an adverse outcome including syncope or progression to complete heart block and need for PPM at 1 year post the procedure. These finding may be considered when evaluating these patients post the procedure. Oxford University Press 2023-05-24 /pmc/articles/PMC10206764/ http://dx.doi.org/10.1093/europace/euad122.389 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 14.1 - Antibradycardia Pacing Perel, N Tovia-Brodie, O Schnur, A Glikson, M Michowitz, Y Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title | Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title_full | Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title_fullStr | Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title_full_unstemmed | Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title_short | Isolated PR prolongation in patients undergoing transcatheter aortic valve implantation |
title_sort | isolated pr prolongation in patients undergoing transcatheter aortic valve implantation |
topic | 14.1 - Antibradycardia Pacing |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206764/ http://dx.doi.org/10.1093/europace/euad122.389 |
work_keys_str_mv | AT pereln isolatedprprolongationinpatientsundergoingtranscatheteraorticvalveimplantation AT toviabrodieo isolatedprprolongationinpatientsundergoingtranscatheteraorticvalveimplantation AT schnura isolatedprprolongationinpatientsundergoingtranscatheteraorticvalveimplantation AT gliksonm isolatedprprolongationinpatientsundergoingtranscatheteraorticvalveimplantation AT michowitzy isolatedprprolongationinpatientsundergoingtranscatheteraorticvalveimplantation |